Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2024

Open Access 01-12-2024 | Research

Comparison of the protective effects of CS/TPP and CS/HPMCP nanoparticles containing berberine in ethanol-induced hepatotoxicity in rat

Authors: Maral Mahboubi Kancha, Morteza Alizadeh, Mohsen Mehrabi

Published in: BMC Complementary Medicine and Therapies | Issue 1/2024

Login to get access

Abstract

Background

Alcoholic liver disease (ALD) is a globally critical condition with no available efficient treatments.

Methods

Herein, we generated chitosan (CS) nanoparticles cross-linked with two different agents, hydroxypropyl methylcellulose phthalate (HPMCP; termed as CS/HPMCP) and tripolyphosphate (TPP; termed as CS/TPP), and loaded them with berberine (BBr; referred to as CS/HPMCP/BBr and CS/TPP/BBr, respectively). Alongside the encapsulation efficiency (EE) and loading capacity (LC), the releasing activity of the nanoparticles was also measured in stimulated gastric fluid (SGF) and stimulated intestinal fluid (SIF) conditions. The effects of the prepared nanoparticles on the viability of mesenchymal stem cells (MSCs) were also evaluated. Ultimately, the protective effects of the nanoparticles were investigated in ALD mouse models.

Results

SEM images demonstrated that CS/HPMCP and CS/TPP nanoparticles had an average size of 235.5 ± 42 and 172 ± 21 nm, respectively. The LC and EE for CS/HPMCP/BBr were calculated as 79.78% and 75.79%, respectively; while the LC and EE for CS/TPP/BBr were 84.26% and 80.05%, respectively. pH was a determining factor for releasing BBr from CS/HPMCP nanoparticles as a higher cargo-releasing rate was observed in a less acidic environment. Both the BBr-loaded nanoparticles increased the viability of MSCs in comparison with their BBr-free counterparts. In vivo results demonstrated CS/HPMCP/BBr and CS/TPP/BBr nanoparticles protected enzymatic liver functionality against ethanol-induced damage. They also prevented histopathological ethanol-induced damage.

Conclusions

Crosslinking CS nanoparticles with HPMCP can mediate controlled drug release in the intestine improving the bioavailability of BBr.
Literature
1.
Yoon YH, Chen CM, Slater ME, Jung MK, White AM. Trends in premature deaths from alcoholic Liver Disease in the U.S., 1999–2018. Am J Prev Med. 2020;59(4):469–80.PubMedPubMedCentralCrossRef
2.
3.
4.
5.
Goldberg D, Ditah IC, Saeian K, Lalehzari M, Aronsohn A, Gorospe EC, et al. Changes in the prevalence of Hepatitis C virus Infection, nonalcoholic steatohepatitis, and alcoholic Liver Disease among patients with Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation. Gastroenterology. 2017;152(5):1090–9e1.PubMedCrossRef
6.
7.
Tilg H, Day CP. Management strategies in alcoholic Liver Disease. Nat Clin Pract Gastroenterol Hepatol. 2007;4(1):24–34.PubMedCrossRef
8.
Li L, Cui H, Li T, Qi J, Chen H, Gao F, et al. Synergistic effect of berberine-based Chinese medicine assembled nanostructures on diarrhea-predominant irritable bowel syndrome in vivo. Front Pharmacol. 2020;11:1210.PubMedPubMedCentralCrossRef
9.
Singh IP, Mahajan S. Berberine and its derivatives: a patent review (2009–2012). Expert Opin Ther Pat. 2013;23(2):215–31.PubMedCrossRef
10.
Germoush MO, Mahmoud AM. Berberine mitigates cyclophosphamide-induced hepatotoxicity by modulating antioxidant status and inflammatory cytokines. J Cancer Res Clin Oncol. 2014;140(7):1103–9.PubMedCrossRef
11.
Knittel T, Mehde M, Grundmann A, Saile B, Scharf JG, Ramadori G. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Histochem Cell Biol. 2000;113(6):443–53.PubMedCrossRef
12.
Wang N, Xu Q, Tan HY, Hong M, Li S, Yuen MF, et al. Berberine Inhibition of Fibrogenesis in a rat model of liver fibrosis and in hepatic stellate cells. Evid Based Complement Alternat Med. 2016;2016:8762345.PubMedPubMedCentral
13.
Li S, Wang N, Tan HY, Chueng F, Zhang ZJ, Yuen MF, et al. Modulation of gut microbiota mediates berberine-induced expansion of immuno-suppressive cells to against alcoholic Liver Disease. Clin Transl Med. 2020;10(4):e112.PubMedPubMedCentralCrossRef
14.
Zhang P, Ma D, Wang Y, Zhang M, Qiang X, Liao M, et al. Berberine protects liver from ethanol-induced oxidative stress and steatosis in mice. Food Chem Toxicol. 2014;74:225–32.PubMedCrossRef
15.
Sreeja S, Krishnan Nair CK. Tumor control by hypoxia-specific chemotargeting of iron-oxide nanoparticle - berberine complexes in a mouse model. Life Sci. 2018;195:71–80.PubMedCrossRef
16.
Wang L, Li H, Wang S, Liu R, Wu Z, Wang C, et al. Enhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulation. AAPS PharmSciTech. 2014;15(4):834–44.PubMedPubMedCentralCrossRef
17.
Zhao Z, Han Z, Naveena K, Lei G, Qiu S, Li X, et al. ROS-Responsive nanoparticle as a berberine carrier for OHC-Targeted therapy of noise-Induced hearing loss. ACS Appl Mater Interfaces. 2021;13(6):7102–14.PubMedCrossRef
18.
Li T, Wang P, Guo W, Huang X, Tian X, Wu G, et al. Natural berberine-based Chinese Herb Medicine assembled nanostructures with modified antibacterial application. ACS Nano. 2019;13(6):6770–81.PubMedCrossRef
19.
Battu SK, Repka MA, Maddineni S, Chittiboyina AG, Avery MA, Majumdar S. Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery. AAPS PharmSciTech. 2010;11(3):1466–75.PubMedPubMedCentralCrossRef
20.
Shen R, Kim JJ, Yao M, Elbayoumi TA. Development and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical. Int J Nanomed. 2016;11:1687–700.
21.
Liu C-S, Zheng Y-R, Zhang Y-F, Long X-Y. Research progress on berberine with a special focus on its oral bioavailability. Fitoterapia. 2016;109:274–82.PubMedCrossRef
22.
Fan D, Wu X, Dong W, Sun W, Li J, Tang X. Enhancement by sodium caprate and sodium deoxycholate of the gastrointestinal absorption of berberine chloride in rats. Drug Dev Ind Pharm. 2013;39(9):1447–56.PubMedCrossRef
23.
Wang Y, Wen B, Yu H, Ding D, Zhang J, Zhang Y, et al. Berberine Hydrochloride-Loaded Chitosan nanoparticles effectively targets and suppresses human nasopharyngeal carcinoma. J Biomed Nanotechnol. 2018;14(8):1486–95.PubMedCrossRef
24.
Saleh SR, Abady MM, Nofal M, Yassa NW, Abdel-Latif MS, Nounou MI, et al. Berberine Nanoencapsulation attenuates Hallmarks of Scoplomine Induced Alzheimer’s-Like Disease in rats. Curr Reviews Clin Experimental Pharmacol. 2021;16(2):139–54.CrossRef
25.
Kapoor R, Singh S, Tripathi M, Bhatnagar P, Kakkar P, Gupta KC. O-hexadecyl-dextran entrapped berberine nanoparticles abrogate high glucose stress induced apoptosis in primary rat hepatocytes. PLoS ONE. 2014;9(2):e89124.PubMedPubMedCentralCrossRef
26.
Bhattacharjee A, Basu A, Ghosh P, Biswas J, Bhattacharya S. Protective effect of selenium nanoparticle against cyclophosphamide induced hepatotoxicity and genotoxicity in Swiss albino mice. J Biomater Appl. 2014;29(2):303–17.PubMedCrossRef
27.
Tabbasam R, Khursid S, Ishaq Y, Malik A. Vivo evaluation of Inorganic Nanoparticle complexes against CCL4 Induced Hepatotoxicity. Curr Drug Deliv. 2021;18(8):1197–203.PubMedCrossRef
28.
Abdelhalim MAK, Moussa SAA, Qaid HA, Al-Ayed MS. Effect of melanin on gold nanoparticle-induced hepatotoxicity and lipid peroxidation in rats. Int J Nanomed. 2018;13:5207–13.CrossRef
29.
Albrahim T, Alonazi MA. Role of Beetroot (Beta vulgaris) Juice on Chronic Nanotoxicity of Silver Nanoparticle-Induced Hepatotoxicity in male rats. Int J Nanomed. 2020;15:3471–82.CrossRef
30.
Ansar S, Abudawood M, Alaraj ASA, Hamed SS. Hesperidin alleviates zinc oxide nanoparticle induced hepatotoxicity and oxidative stress. BMC Pharmacol Toxicol. 2018;19(1):65.PubMedPubMedCentralCrossRef
31.
Mahya S, Ai J, Shojae S, Khonakdar HA, Darbemamieh G, Shirian S. Berberine loaded chitosan nanoparticles encapsulated in polysaccharide-based hydrogel for the repair of spinal cord. Int J Biol Macromol. 2021;182:82–90.PubMedCrossRef
32.
Mohammed MA, Syeda JTM, Wasan KM, Wasan EK. An overview of Chitosan Nanoparticles and its application in Non-parenteral Drug Delivery. Pharmaceutics. 2017;9(4).
33.
Du H, Liu M, Yang X, Zhai G. The design of pH-sensitive chitosan-based formulations for gastrointestinal delivery. Drug Discovery Today. 2015;20(8):1004–11.PubMedCrossRef
34.
Makhlof A, Tozuka Y, Takeuchi H. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci. 2011;42(5):445–51.PubMedCrossRef
35.
Fan W, Yan W, Xu Z, Ni H. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surf B. 2012;90:21–7.CrossRef
36.
Pedroso-Santana S, Fleitas‐Salazar N. Ionotropic gelation method in the synthesis of nanoparticles/microparticles for biomedical purposes. Polym Int. 2020;69(5):443–7.CrossRef
37.
Kruger NJ. The Bradford method for protein quantitation. The Protein Protocols Handbook. 2009:17–24.
38.
Alalawy AI, El Rabey HA, Almutairi FM, Tayel AA, Al-Duais MA, Zidan NS et al. Effectual anticancer potentiality of loaded bee venom onto fungal chitosan nanoparticles. International journal of polymer science. 2020;2020.
39.
Li P, Dai Y-N, Zhang J-P, Wang A-Q, Wei Q. Chitosan-Alginate nanoparticles as a novel drug delivery system for nifedipine. Int J Biomedical Science: IJBS. 2008;4(3):221.CrossRef
40.
Díaz MS, Freile ML, Gutiérrez MI. Solvent effect on the UV/Vis absorption and fluorescence spectroscopic properties of berberine. Photochem Photobiol Sci. 2009;8(7):970–4.PubMedCrossRef
41.
Naveen NR, Kurakula M, Gowthami B. Process optimization by response surface methodology for preparation and evaluation of methotrexate loaded chitosan nanoparticles. Materials Today: Proceedings. 2020;33:2716-24.
42.
Shield KD, Parry C, Rehm J. Chronic Diseases and conditions related to alcohol use. Alcohol Res. 2013;35(2):155–73.PubMed
43.
Roerecke M, Vafaei A, Hasan OSM, Chrystoja BR, Cruz M, Lee R, et al. Alcohol consumption and risk of liver Cirrhosis: a systematic review and Meta-analysis. Am J Gastroenterol. 2019;114(10):1574–86.PubMedPubMedCentralCrossRef
44.
45.
Hamidi M, Kozani PS, Kozani PS, Pierre G, Michaud P, Delattre C. Marine Bacteria versus Microalgae: who is the best for Biotechnological Production of Bioactive compounds with antioxidant properties and other Biological applications? Mar Drugs. 2020;18(1):28.CrossRef
46.
Contreras-Zentella ML, Villalobos-García D, Hernández-Muñoz R. Ethanol metabolism in the liver, the induction of oxidant stress, and the antioxidant Defense System. Antioxidants. 2022;11(7):1258.PubMedPubMedCentralCrossRef
47.
Frazier TH, Stocker AM, Kershner NA, Marsano LS, McClain CJ. Treatment of alcoholic Liver Disease. Th Adv Gastroenterol. 2011;4(1):63–81.CrossRef
48.
Parker R, McCune CA. Diagnosis and treatment of alcoholic hepatitis. Frontline Gastroenterol. 2014;5(2):123–9.PubMedCrossRef
49.
50.
Song D, Hao J, Fan D. Biological properties and clinical applications of berberine. Front Med. 2020;14(5):564–82.PubMedCrossRef
51.
52.
Mohammadzadeh N, Mehri S, Hosseinzadeh H. Berberis vulgaris and its constituent berberine as antidotes and protective agents against natural or chemical toxicities. Iran J Basic Med Sci. 2017;20(5):538–51.PubMedPubMedCentral
53.
Zhu WQ, Wu HY, Sun ZH, Guo Y, Ge TT, Li BJ, et al. Current evidence and future directions of Berberine intervention in Depression. Front Pharmacol. 2022;13:824420.PubMedPubMedCentralCrossRef
54.
55.
Haftcheshmeh SM, Abedi M, Mashayekhi K, Mousavi MJ, Navashenaq JG, Mohammadi A, et al. Berberine as a natural modulator of inflammatory signaling pathways in the immune system: focus on NF-κB, JAK/STAT, and MAPK signaling pathways. Phytother Res. 2022;36(3):1216–30.PubMedCrossRef
56.
Ai X, Yu P, Peng L, Luo L, Liu J, Li S, et al. Berberine: a review of its Pharmacokinetics properties and therapeutic potentials in Diverse Vascular Diseases. Front Pharmacol. 2021;12:762654.PubMedPubMedCentralCrossRef
57.
Javed Iqbal M, Quispe C, Javed Z, Sadia H, Qadri QR, Raza S, et al. Nanotechnology-based strategies for Berberine Delivery System in Cancer Treatment: pulling Strings to keep Berberine in Power. Front Mol Biosci. 2020;7:624494.PubMedCrossRef
58.
Yanat M, Schroën K. Preparation methods and applications of chitosan nanoparticles; with an outlook toward reinforcement of biodegradable packaging. Reactive and Functional Polymers. 2021;161:104849.CrossRef
59.
Sharifi-Rad J, Quispe C, Butnariu M, Rotariu LS, Sytar O, Sestito S, et al. Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment. Cancer Cell Int. 2021;21(1):318.PubMedPubMedCentralCrossRef
60.
Sacco P, Pedroso-Santana S, Kumar Y, Joly N, Martin P, Bocchetta P. Ionotropic gelation of chitosan flat structures and potential applications. Molecules. 2021;26(3):660.PubMedPubMedCentralCrossRef
61.
Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2001;48(2):139–57.PubMedCrossRef
62.
Kim IH, Park JH, Cheong IW, Kim JH. Swelling and drug release behavior of tablets coated with aqueous hydroxypropyl methylcellulose phthalate (HPMCP) nanoparticles. J Control Release. 2003;89(2):225–33.PubMedCrossRef
63.
Xu W, Gao Q, Xu Y, Wu D, Sun Y. pH-Controlled drug release from mesoporous silica tablets coated with hydroxypropyl methylcellulose phthalate. Mater Res Bull. 2009;44(3):606–12.CrossRef
64.
Singh B, Maharjan S, Jiang T, Kang SK, Choi YJ, Cho CS. Attuning hydroxypropyl methylcellulose phthalate to oral delivery vehicle for effective and selective delivery of protein vaccine in ileum. Biomaterials. 2015;59:144–59.PubMedCrossRef
65.
Mylonas C, Kouretas D. Lipid peroxidation and tissue damage. In Vivo. 1999;13(3):295–309.PubMed
66.
Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438.PubMedPubMedCentralCrossRef
67.
Niki E, Yoshida Y, Saito Y, Noguchi N. Lipid peroxidation: mechanisms, inhibition, and biological effects. Biochem Biophys Res Commun. 2005;338(1):668–76.PubMedCrossRef
68.
Li J, Pan Y, Kan M, Xiao X, Wang Y, Guan F, et al. Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase. Life Sci. 2014;98(1):24–30.PubMedCrossRef
Metadata
Title
Comparison of the protective effects of CS/TPP and CS/HPMCP nanoparticles containing berberine in ethanol-induced hepatotoxicity in rat
Authors
Maral Mahboubi Kancha
Morteza Alizadeh
Mohsen Mehrabi
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2024
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-023-04318-9

Other articles of this Issue 1/2024

BMC Complementary Medicine and Therapies 1/2024 Go to the issue

Research

Wine- and stir-frying processing of Cuscutae Semen enhance its ability to alleviate oxidative stress and apoptosis via the Keap 1-Nrf2/HO-1 and PI3K/AKT pathways in H2O2-challenged KGN human granulosa cell line

Research

Encapsulation of propolis extracted with methylal in the chitosan nanoparticles and its antibacterial and cell cytotoxicity studies

Research

Phytochemical analysis and evaluation of its antioxidant, antimicrobial, and cytotoxic activities for different extracts of Casuarina equisetifolia

Research

Knowledge, attitude, and practice of Iranian adults toward Persian Medicine: a national survey

Research

Supplementation of papaya leaf juice has beneficial effects on glucose homeostasis in high fat/high sugar-induced obese and prediabetic adult mice

Research

Protective effect of Ganoderma lucidum-fermented crop extracts against hydrogen peroxide- or β-amyloid-induced damage in human neuronal SH-SY5Y cells